CDMO Kindeva has announced the appointment of Melanie Cerullo as Chief Quality Officer. Cerullo was most recently Chief Quality and Regulatory Officer at Recipharm’s ReciBioPharm business unit and previously served in quality roles at Wave Life Sciences, Ameridose, and Amgen.
Since the beginning of 2024, Kindeva has expanded its facilities with the acquisition of Summit Biosciences, the opening of new laboratories in Minnesota, and the addition of an additional LGWP propellant MDI manufacturing line at its facility in Loughborough, UK as well as added analytical laboratory space at that facility.
Kindeva CEO Milton Boyer commented, “Melanie’s expertise and impressive track record in FDA, EMA, and ICH regulations will be pivotal in our mission to foster operational growth and innovation across the company. As we continue to expand global capacity to meet the considerable demand for Kindeva’s services, we remain extremely committed to ensuring that the medicines we develop and manufacture on behalf of our customers and their patients are done so to the highest standards.”
Read the Kindeva press release
